The Latest Headlines at American Banking and Market News
Needham & Company LLC Reaffirms Buy Rating for Genpact (NYSE:G)
Needham & Company LLC restated their buy rating on shares of Genpact (NYSE:G – Free Report) in a report published on Friday morning, Benzinga reports. They currently have a $40.00 target price on the business services provider’s... More of this article »
Trex (NYSE:TREX) PT Lowered to $105.00 at Robert W. Baird
Trex (NYSE:TREX – Free Report) had its target price lowered by Robert W. Baird from $110.00 to $105.00 in a research note released on Friday morning, Benzinga reports. The firm currently has a neutral rating on the construction... More of this article »
Tapestry (NYSE:TPR) PT Lowered to $50.00 at Robert W. Baird
Tapestry (NYSE:TPR – Free Report) had its price objective reduced by Robert W. Baird from $52.00 to $50.00 in a report issued on Friday, Benzinga reports. They currently have an outperform rating on the luxury accessories retailer’s... More of this article »
Monopar Therapeutics (NASDAQ:MNPR) Earns “Buy” Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of Monopar Therapeutics (NASDAQ:MNPR – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $2.00 price objective on the stock. Separately,... More of this article »
Playa Hotels & Resorts (NASDAQ:PLYA) Price Target Cut to $14.00
Playa Hotels & Resorts (NASDAQ:PLYA – Free Report) had its target price lowered by Deutsche Bank Aktiengesellschaft from $16.00 to $14.00 in a research note published on Thursday morning, Benzinga reports. The firm currently... More of this article »
LifeMD (NASDAQ:LFMD) Price Target Raised to $15.00 at Cantor Fitzgerald
LifeMD (NASDAQ:LFMD – Free Report) had its price objective lifted by Cantor Fitzgerald from $13.00 to $15.00 in a research report released on Thursday morning, Benzinga reports. The brokerage currently has an overweight rating... More of this article »
Robert W. Baird Cuts Charles River Laboratories International (NYSE:CRL) Price Target to $270.00
Charles River Laboratories International (NYSE:CRL – Free Report) had its price objective reduced by Robert W. Baird from $282.00 to $270.00 in a report released on Friday morning, Benzinga reports. They currently have an outperform... More of this article »
ServiceNow (NYSE:NOW) Earns Outperform Rating from Wolfe Research
Wolfe Research restated their outperform rating on shares of ServiceNow (NYSE:NOW – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. Wolfe Research currently has a $830.00 price target... More of this article »
Canaccord Genuity Group Cuts Progyny (NASDAQ:PGNY) Price Target to $37.00
Progyny (NASDAQ:PGNY – Free Report) had its price objective trimmed by Canaccord Genuity Group from $46.00 to $37.00 in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a buy rating... More of this article »
CleanSpark’s (CLSK) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of CleanSpark (NASDAQ:CLSK – Free Report) in a research note published on Friday morning, Benzinga reports. HC Wainwright currently has a $27.00 target price on the stock. A... More of this article »
Barclays Boosts Hanesbrands (NYSE:HBI) Price Target to $5.00
Hanesbrands (NYSE:HBI – Free Report) had its target price increased by Barclays from $4.00 to $5.00 in a research note published on Friday morning, Benzinga reports. The brokerage currently has an equal weight rating on the textile... More of this article »
Chuy’s (NASDAQ:CHUY) Earns Overweight Rating from Stephens
Stephens reiterated their overweight rating on shares of Chuy’s (NASDAQ:CHUY – Free Report) in a report published on Friday, Benzinga reports. The firm currently has a $40.00 price objective on the restaurant operator’s... More of this article »
National Vision (NASDAQ:EYE) PT Lowered to $16.00 at Barclays
National Vision (NASDAQ:EYE – Free Report) had its target price cut by Barclays from $19.00 to $16.00 in a report published on Friday morning, Benzinga reports. They currently have an equal weight rating on the stock. Separately,... More of this article »